次世代定序市場：按產品類型、定序方法、應用、最終用戶和地區分類。

Next Generation Sequencing Market, By Product Type, By Sequencing Type, By Application, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，次世代定序市場規模將達到217.6億美元，到2033年將達到575.4億美元。預計從2026年到2033年，其複合年成長率將達到14.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	217.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	14.90%	2033年市場規模預測：	575.4億美元

次世代定序（NGS）是一種高通量DNA測序技術，與第一代桑格定序相比，它顯著降低了DNA定序成本，並提高了定序速度和處理能力。 NGS不僅使研究人員能夠對整個基因組定序，還能大規模分析基因活性和表現模式。自2005年問世以來，NGS平台取得了顯著進展，單次運行即可對數千至數百萬個DNA片段定序。這種大規模平行定定序徹底改變了生物學和生物醫學研究，使基因組研究能夠進行全面的表徵和發現。 NGS的應用領域十分廣泛，包括遺傳學、腫瘤學、藥物基因體學和個人化醫療等。

市場動態

全球次世代定序市場正蓬勃發展，其成長主要得益於基因組學和精準醫療在多種疾病領域的應用不斷拓展。癌症發生率的上升以及藥物基因體學的日益普及，推動了臨床診斷和監測領域對新一代定序平台的需求。基因組學研究活動的活性化，加上定序成本的持續下降以及攜帶式和方便用戶使用型定序設備的推出，也促進了市場成長。然而，挑戰依然存在，例如新一代定序產生的大量資料所帶來的資料管理和分析難題，以及生物資訊學知識的匱乏。另一方面，單細胞分析的應用以及基於雲端的新一代定序資料管理解決方案的開發，為市場帶來了巨大的成長機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球次世代定序市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球次世代定序市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球次世代定序市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Thermo Fisher Scientific Inc.
Agilent Technologies, Inc
bioMerieux SA
F. Hoffmann-La Roche Ltd
QIAGEN
Illumina, Inc.
Oxford Nanopore Technologies plc.
BGI
PerkinElmer Genomics
Bio-Rad Laboratories Inc.
Pacific Biosciences
10x Genomics
Promega Corporation
Macrogen Inc.
Eurofins Scientific
DNASTAR Inc.
CD Genomics

第10章分析師觀點

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI158

Next Generation Sequencing Market is estimated to be valued at USD 21.76 Bn in 2026 and is expected to reach USD 57.54 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 21.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	14.90%	2033 Value Projection:	USD 57.54 Bn

Next Generation Sequencing (NGS) refers to the high-throughput DNA sequencing technologies that have substantially decreased the cost and increased the speed and throughput of DNA sequencing as compared to the first-generation Sanger sequencing. NGS allows researchers to sequence entire genomes, as well as to analyze the patterns of gene activity or expression on a large scale. Since its discovery in 2005, there have been tremendous improvements in NGS platforms which has enabled the sequencing of thousands to millions of DNA fragments in a single run. This massively parallel sequencing has revolutionized biological and biomedical research by allowing comprehensive characterization and discovery in genomic research. NGS finds applications across various fields including genetics, oncology, pharmacogenomics and personalized medicine.

Market Dynamics

The global next generation sequencing market growth is driven by growing applications of genomics and precision medicine across various diseases. Rising prevalence of cancer and growing focus on pharmacogenomics is fueling the demand for NGS platforms in clinical diagnosis and monitoring. Growing genomics research activities, coupled with continuous decline in sequencing costs and introduction of portable and user-friendly sequencing instruments is also boosting the market growth. However, data management and analysis issues due to the massive amount of data generated from NGS, and limited bioinformatics knowledge remains a challenge. Meanwhile, developments in single-cell applications and cloud-based solutions for NGS data management presents lucrative growth opportunities.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global next generation sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Thermo Fisher Scientific Inc., Agilent Technologies Inc, bioMerieux SA, F. Hoffmann-La Roche Ltd, QIAGEN, Illumina Inc., Oxford Nanopore Technologies plc., BGI, PerkinElmer Genomics, Bio-Rad Laboratories Inc., Pacific Biosciences, 10x Genomics, Promega Corporation, Macrogen Inc., Eurofins Scientific, DNASTAR Inc., and CD Genomics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global next generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation sequencing market.

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2026 - 2033)
Instruments
Reagents & Consumables
Sequencing Type Insights (Revenue, USD Bn, 2026 - 2033)
Whole Genome Sequencing
Whole Exome Sequencing
RNA Sequencing
Targeted Re-sequencing
Others
Application Insights (Revenue, USD Bn, 2026 - 2033)
Drug Discovery
Personalized Medicine
Genetic Screening
Diagnostics
Others
End User Insights (Revenue, USD Bn, 2026 - 2033)
Hospitals & Clinics
Academic & Research Institutes
Biopharmaceutical Companies
Clinical Laboratories
Others
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
- Pradeep Tripathi
Key Players Insights
Thermo Fisher Scientific Inc.
Agilent Technologies Inc
bioMerieux SA
F. Hoffmann-La Roche Ltd
QIAGEN
Illumina Inc.
Oxford Nanopore Technologies plc.
BGI
PerkinElmer Genomics
Bio-Rad Laboratories Inc.
Pacific Biosciences
10x Genomics
Promega Corporation
Macrogen Inc.
Eurofins Scientific
DNASTAR Inc.
CD Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sequencing Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Next Generation Sequencing Market, By Product Type, 2026 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Reagents & Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

5. Global Next Generation Sequencing Market, By Sequencing Type, 2026 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Whole Genome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Whole Exome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
RNA Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Targeted Re-sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

6. Global Next Generation Sequencing Market, By Application, 2026 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Personalized Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Genetic Screening
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

7. Global Next Generation Sequencing Market, By End User, 2026 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Clinical Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

8. Global Next Generation Sequencing Market, By Region, 2026 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Agilent Technologies, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Oxford Nanopore Technologies plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BGI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PerkinElmer Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pacific Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10x Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Macrogen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
DNASTAR Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CD Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies